ESPEN practical guideline: Home parenteral nutrition.

Central venous access device Home parenteral nutrition Intestinal failure Multidisciplinary team Parenteral nutrition admixture Patient training

Journal

Clinical nutrition (Edinburgh, Scotland)
ISSN: 1532-1983
Titre abrégé: Clin Nutr
Pays: England
ID NLM: 8309603

Informations de publication

Date de publication:
03 2023
Historique:
received: 29 11 2022
accepted: 05 12 2022
pubmed: 17 2 2023
medline: 3 3 2023
entrez: 16 2 2023
Statut: ppublish

Résumé

This guideline will inform physicians, nurses, dieticians, pharmacists, caregivers and other home parenteral nutrition (HPN) providers, as well as healthcare administrators and policy makers, about appropriate and safe HPN provision. This guideline will also inform patients requiring HPN. The guideline is based on previous published guidelines and provides an update of current evidence and expert opinion; it consists of 71 recommendations that address the indications for HPN, central venous access device (CVAD) and infusion pump, infusion catheter and CVAD site care, nutritional admixtures, program monitoring and management. Meta-analyses, systematic reviews and single clinical trials based on clinical questions were searched according to the PICO format. The evidence was evaluated and used to develop clinical recommendations implementing Scottish Intercollegiate Guidelines Network methodology. The guideline was commissioned and financially supported by ESPEN and members of the guideline group were selected by ESPEN.

Identifiants

pubmed: 36796121
pii: S0261-5614(22)00427-7
doi: 10.1016/j.clnu.2022.12.003
pii:
doi:

Types de publication

Journal Article Practice Guideline Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

411-430

Informations de copyright

Copyright © 2022 © 2023 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of interest The expert members of the working group were accredited by the ESPEN Guidelines Group, the ESPEN Education and Clinical Practice Committee, and the ESPEN executive. All expert members have declared their individual conflicts of interest according to the rules of the International Committee of Medical Journal Editors (ICMJE). If potential conflicts were indicated, they were reviewed by the ESPEN guideline officers and, in cases of doubts, by the ESPEN executive. None of the expert panel had to be excluded from the working group or from co-authorship because of serious conflicts. The conflict of interest forms are stored at the ESPEN guideline office and can be reviewed by ESPEN members with legitimate interest upon request to the ESPEN executive.

Auteurs

Loris Pironi (L)

University of Bologna, Department of Medical and Surgical Sciences, Italy; IRCCS AOUBO, Centre for Chronic Intestinal Failure - Clinical Nutrition and Metabolism Unit, Italy. Electronic address: loris.pironi@unibo.it.

Kurt Boeykens (K)

Vitaz Hospital, Nutrition Support Team, Sint-Niklaas, Belgium.

Federico Bozzetti (F)

Faculty of Medicine, University of Milan, Italy.

Francisca Joly (F)

Beaujon Hospital, APHP, University of Paris VII, Clichy, France.

Stanislaw Klek (S)

Surgical Oncology Clinic, The Maria Sklodowska-Curie National Cancer Institute, Krakow, Poland.

Simon Lal (S)

Salford Royal NHS Foundation Trust, Salford, UK.

Marek Lichota (M)

Intestinal Failure Patients Association "Appetite for Life", Cracow, Poland.

Stefan Mühlebach (S)

Division of Clinical Pharmacy and Epidemiology and Hospital Pharmacy, University of Basel, Basel, Switzerland.

Andre Van Gossum (A)

Hôpital Erasme and Institut Bordet, Brussels, Belgium.

Geert Wanten (G)

Intestinal Failure Unit, Radboud University Medical Centre, Nijmegen, the Netherlands.

Carolyn Wheatley (C)

Support and Advocacy Group for People on Home Artificial Nutrition (PINNT), UK.

Stephan C Bischoff (SC)

University of Hohenheim, Institute of Nutritional Medicine, Stuttgart, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH